NEW YORK, Sept. 18, 2025 /PRNewswire/ — Clinical.ly, a leading provider of intuitive clinical research technology, just completed its inaugural Clinical.ly Research Working Group meeting, a quarterly forum designed to give research sites a direct voice in shaping the future of clinical technology.
The Working Group convenes coordinators, regulatory teams, and site leadership from academic institutions, hospitals, health systems, independent sites, and site networks. Each session provides an opportunity to examine operational and regulatory challenges, exchange solutions, and preview early concepts and beta releases.
“Research sites know better than anyone what works—and what doesn’t,” said Henry Kravchenko, Chief Executive Officer of Clinical.ly. “This initiative ensures that their voices drive innovation. Our commitment is to implement at least one feature, fix, or improvement identified in each meeting before the next quarterly session.”
Participation is open to all research sites, regardless of whether they are Clinical.ly customers. Members benefit from peer collaboration, early access to innovation, and the assurance that their feedback directly informs the company’s product roadmap.
The launch of the Clinical.ly Research Working Group underscores the company’s commitment to building technology with research sites, not just for them—embedding collaboration, education, and accountability into every product decision.
About Clinical.ly
Clinical.ly delivers modern, intuitive software that improves operational efficiency, reduces regulatory burden, accelerates study startup, and maintains compliance for clinical research sites. The Clinical.ly ResearchSuite™ includes dedicated modules requested by sites and health systems, including eReg, eSource, eConsent, ClinicallyPay, and ClinicallySign, to keep sites in control of their data, operations, and compliance needs.
Learn more about Clinical.ly at https://clinical.ly
SOURCE Clinical.ly
CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…
Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…
MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…
Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…
PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…